BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 35385705)

  • 1. Deadenylase-dependent mRNA decay of GDF15 and FGF21 orchestrates food intake and energy expenditure.
    Katsumura S; Siddiqui N; Goldsmith MR; Cheah JH; Fujikawa T; Minegishi G; Yamagata A; Yabuki Y; Kobayashi K; Shirouzu M; Inagaki T; Huang TH; Musi N; Topisirovic I; Larsson O; Morita M
    Cell Metab; 2022 Apr; 34(4):564-580.e8. PubMed ID: 35385705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic posttranscriptional network comprised of CCR4-NOT deadenylase and FGF21 maintains systemic metabolic homeostasis.
    Morita M; Siddiqui N; Katsumura S; Rouya C; Larsson O; Nagashima T; Hekmatnejad B; Takahashi A; Kiyonari H; Zang M; St-Arnaud R; Oike Y; Giguère V; Topisirovic I; Okada-Hatakeyama M; Yamamoto T; Sonenberg N
    Proc Natl Acad Sci U S A; 2019 Apr; 116(16):7973-7981. PubMed ID: 30926667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stress-induced FGF21 and GDF15 in obesity and obesity resistance.
    Keipert S; Ost M
    Trends Endocrinol Metab; 2021 Nov; 32(11):904-915. PubMed ID: 34526227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic Small Ubiquitin-Related Modifier (SUMO)-Specific Protease 2 Controls Systemic Metabolism Through SUMOylation-Dependent Regulation of Liver-Adipose Tissue Crosstalk.
    Liu Y; Dou X; Zhou WY; Ding M; Liu L; Du RQ; Guo L; Qian SW; Tang Y; Yang QQ; Pan DN; Li XY; Lu Y; Cheng JK; Tang QQ
    Hepatology; 2021 Oct; 74(4):1864-1883. PubMed ID: 33934381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucagon augments the secretion of FGF21 and GDF15 in MASLD by indirect mechanisms.
    Richter MM; Kemp IM; Heebøll S; Winther-Sørensen M; Kjeldsen SAS; Jensen NJ; Nybing JD; Linden FH; Høgh-Schmidt E; Boesen MP; Madsbad S; Schiødt FV; Nørgaard K; Schmidt S; Gluud LL; Haugaard SB; Holst JJ; Nielsen S; Rungby J; Wewer Albrechtsen NJ
    Metabolism; 2024 Jul; 156():155915. PubMed ID: 38631460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low protein-induced increases in FGF21 drive UCP1-dependent metabolic but not thermoregulatory endpoints.
    Hill CM; Laeger T; Albarado DC; McDougal DH; Berthoud HR; Münzberg H; Morrison CD
    Sci Rep; 2017 Aug; 7(1):8209. PubMed ID: 28811495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic SIRT1 attenuates hepatic steatosis and controls energy balance in mice by inducing fibroblast growth factor 21.
    Li Y; Wong K; Giles A; Jiang J; Lee JW; Adams AC; Kharitonenkov A; Yang Q; Gao B; Guarente L; Zang M
    Gastroenterology; 2014 Feb; 146(2):539-49.e7. PubMed ID: 24184811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth differentiation factor-15 is an IFN-γ regulated mediator of infection-induced weight loss and the hepatic FGF21 response.
    Reyes J; Zhao Y; Pandya K; Yap GS
    Brain Behav Immun; 2024 Feb; 116():24-33. PubMed ID: 38013040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary medium-chain fatty acids reduce food intake via the GDF15-GFRAL axis in mice.
    Kanta JM; Deisen L; Johann K; Holm S; Lundsgaard A; Lund J; Jähnert M; Schürmann A; Clemmensen C; Kiens B; Fritzen AM; Kleinert M
    Mol Metab; 2023 Aug; 74():101760. PubMed ID: 37356805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The roles of FGF21 and GDF15 in mediating the mitochondrial integrated stress response.
    Jena J; García-Peña LM; Pereira RO
    Front Endocrinol (Lausanne); 2023; 14():1264530. PubMed ID: 37818094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TGF-b superfamily cytokine MIC-1/GDF15 is a physiological appetite and body weight regulator.
    Tsai VW; Macia L; Johnen H; Kuffner T; Manadhar R; Jørgensen SB; Lee-Ng KK; Zhang HP; Wu L; Marquis CP; Jiang L; Husaini Y; Lin S; Herzog H; Brown DA; Sainsbury A; Breit SN
    PLoS One; 2013; 8(2):e55174. PubMed ID: 23468844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibroblast growth factor 21 increases hepatic oxidative capacity but not physical activity or energy expenditure in hepatic peroxisome proliferator-activated receptor γ coactivator-1α-deficient mice.
    Fletcher JA; Linden MA; Sheldon RD; Meers GM; Morris EM; Butterfield A; Perfield JW; Rector RS; Thyfault JP
    Exp Physiol; 2018 Mar; 103(3):408-418. PubMed ID: 29215172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toward reconciling the roles of FGF21 in protein appetite, sweet preference, and energy expenditure.
    Solon-Biet SM; Clark X; Bell-Anderson K; Rusu PM; Perks R; Freire T; Pulpitel T; Senior AM; Hoy AJ; Aung O; Le Couteur DG; Raubenheimer D; Rose AJ; Conigrave AD; Simpson SJ
    Cell Rep; 2023 Dec; 42(12):113536. PubMed ID: 38060447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An adipocyte-specific defect in oxidative phosphorylation increases systemic energy expenditure and protects against diet-induced obesity in mouse models.
    Choi MJ; Jung SB; Lee SE; Kang SG; Lee JH; Ryu MJ; Chung HK; Chang JY; Kim YK; Hong HJ; Kim H; Kim HJ; Lee CH; Mardinoglu A; Yi HS; Shong M
    Diabetologia; 2020 Apr; 63(4):837-852. PubMed ID: 31925461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of diurnal energy balance by mitokines.
    Klaus S; Igual Gil C; Ost M
    Cell Mol Life Sci; 2021 Apr; 78(7):3369-3384. PubMed ID: 33464381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined genetic deletion of GDF15 and FGF21 has modest effects on body weight, hepatic steatosis and insulin resistance in high fat fed mice.
    Patel S; Haider A; Alvarez-Guaita A; Bidault G; El-Sayed Moustafa JS; Guiu-Jurado E; Tadross JA; Warner J; Harrison J; Virtue S; Scurria F; Zvetkova I; Blüher M; Small KS; O'Rahilly S; Savage DB
    Mol Metab; 2022 Nov; 65():101589. PubMed ID: 36064109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FGF21 is required for the metabolic benefits of IKKε/TBK1 inhibition.
    Reilly SM; Abu-Odeh M; Ameka M; DeLuca JH; Naber MC; Dadpey B; Ebadat N; Gomez AV; Peng X; Poirier B; Walk E; Potthoff MJ; Saltiel AR
    J Clin Invest; 2021 May; 131(10):. PubMed ID: 33822771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic glucuronyl C5-epimerase combats obesity by stabilising GDF15.
    He F; Jiang H; Peng C; Wang T; Xiao R; Chen M; Song N; Du Z; Wang H; Ding X; Shao Y; Fang J; Zang Y; Hua R; Li J; Ding K
    J Hepatol; 2023 Sep; 79(3):605-617. PubMed ID: 37217020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole-body and adipose tissue-specific mechanisms underlying the metabolic effects of fibroblast growth factor 21 in the Siberian hamster.
    Lewis JE; Monnier C; Marshall H; Fowler M; Green R; Cooper S; Chiotellis A; Luckett J; Perkins AC; Coskun T; Adams AC; Samms RJ; Ebling FJP; Tsintzas K
    Mol Metab; 2020 Jan; 31():45-54. PubMed ID: 31918921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GDF15 promotes weight loss by enhancing energy expenditure in muscle.
    Wang D; Townsend LK; DesOrmeaux GJ; Frangos SM; Batchuluun B; Dumont L; Kuhre RE; Ahmadi E; Hu S; Rebalka IA; Gautam J; Jabile MJT; Pileggi CA; Rehal S; Desjardins EM; Tsakiridis EE; Lally JSV; Juracic ES; Tupling AR; Gerstein HC; Paré G; Tsakiridis T; Harper ME; Hawke TJ; Speakman JR; Blondin DP; Holloway GP; Jørgensen SB; Steinberg GR
    Nature; 2023 Jul; 619(7968):143-150. PubMed ID: 37380764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.